Security Snapshot

Renalytix plc - Ordinary shares, nominal value 0.0025 per share Institutional Ownership

CUSIP: G7489R108

13F Institutional Holders and Ownership History from Q1 2019 to Q2 2022

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Ordinary shares, nominal value 0.0025 per share
Shares outstanding
328,915,843
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share is tracked under CUSIP G7489R108.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 2 to 0 between Q1 2022 and Q2 2022.
  • Reported value moved from $622,000 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP G7489R108?
CUSIP G7489R108 identifies G7489R108 - Renalytix plc - Ordinary shares, nominal value 0.0025 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of Renalytix plc - Ordinary shares, nominal value 0.0025 per share across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q2 0 $0 -$622,000 0
2022 Q1 175,206 $622,000 -$401,000 $3.54 2
2021 Q4 222,931 $1,872,000 -$3,386 $8.40 3
2021 Q3 223,334 $2,183,000 -$188,252 $9.78 3
2021 Q2 242,611 $3,620,000 -$1,478,238 $14.92 3
2021 Q1 341,675 $4,431,000 -$308,296 $12.97 2
2020 Q4 365,446 $2,435,000 -$266,332 $6.66 2
2020 Q3 409,311 $2,246,000 -$1,181,473 $5.49 3
2020 Q2 630,301 $4,172,000 +$689,922 $6.55 3
2020 Q1 526,573 $1,482,000 +$167,772 $2.73 3
2019 Q4 463,756 $2,148,000 +$712,033 $4.82 3
2019 Q3 313,019 $943,000 +$101,003 $3.01 2
2019 Q2 278,519 $984,000 +$789,294 $3.48 2
2019 Q1 62,000 $88,000 +$88,000 $1.42 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .